Ads
related to: benefits of stem cell research
Search results
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis...
Benzinga· 3 days agoIn heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety
How Long Concussion could offer new insights into Long Covid
BBC News· 12 hours agoMidway through 2023, the neurologist Ioannis Mavroudis was working his way through the latest...
Masdar City to Showcase Its Life Sciences Hub at BIO24 in San Diego
StreetInsider· 2 days agoMasdar City to showcase why they are the leading destination for the life sciences sector at...
The $35 eye mask the multimillionaire XPrize founder swears by for better sleep
Business Insider· 5 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Bronchial Rheoplasty Unplugs Mucus in Chronic Bronchitis
Medscape· 3 days ago"Mucus plugging, opacities within the lumen of an airway seen on CT scan, is a relatively new...
Three Indian CDMOs ready to seize the BIOSECURE Act opportunity
BioPharma-Reporter· 13 hours agoNotably, major players like WuXi AppTec, WuXi Bio, BGI Genomics, MGI, and its subsidiary Complete...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Forrest City Times-Herald· 3 days agoJohnson & Johnson today announced data from the Phase 3 PERSEUS study showing deepening of responses and sustained minimal residual disease (MRD) negativity at both 10-5 and 10-6 levels with ...
Dry Eye Syndrome Medical Devices and Procedures
Healthline· 6 days agoIf home remedies and artificial tears aren’t adequately addressing your dry eye symptoms, a doctor may recommend a medical device or procedure in...
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Valley City Times Record· 3 days ago"Over the past two years, TECVAYLI has helped over 10,000 patients with relapsed or refractory multiple myeloma," said Rachel Kobos, M.D., Vice President, Oncology Research
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoMitsubishi Tanabe Pharma America to Highlight Expansive ALS Research at the European Network to Cure ALS (ENCALS) 2024 Meeting PR Newswire JERSEY CITY, N.J., June 5, 2024 ...
